Pharmaco-Fakery

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

On the other hand, if we don't keep up the pressure on counterfeiting in the US, we may share the plight of the developing world, where nearly 25% of all drugs sold are fakes.

Related Content:

From the EditorProcess ValidationQuality SystemsViewpointsDevelopmentPharmaceutical Technology-12-02-2004
Novartis and Monte Rosa Therapeutics Form $2.1 Billion Global License Agreement for MGD-based Therapeutics
BioDuro-Sundia Opens New Kilogram Laboratory at Shanghai Site
Regulatory Collaboration on Mpox Treatments Summarized in Report